Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 24 min ago
Peer-reviewedLicence not statedDrug Discovery Today

Microfluidic models for adoptive cell-mediated cancer immunotherapies

  • Giulia Adriani
  • Andrea Pavesi
  • Anthony T. Tan
  • Antonio Bertoletti
  • Jean Paul Thiery
  • Roger D. Kamm
Open at sourcePDFDOICite

Related

  1. 345 Neoantigen-targeted adoptive cell therapy in bladder cancer: feasibility of isolating and enriching tumor-reactive infiltrating lymphocytes
    Mary Thomas, Shari Pilon-Thomas, Matthew Beatty +13
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  2. Characterizing the role of monocytes in T cell cancer immunotherapy using a 3d microfluidic model
    Siew Cheng Wong, Sharon Wei Ling Lee, Giulia Adriani +5
    Frontiers in ImmunologyPeer-reviewedCC BYFull text109 citedImmunologyHAL
  3. Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies
    Qingyu Chen, Yuxin Zhu, Shilin Ye +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Editorial: Community series in new insights into innate immune cell-based immunotherapies in cancer, volume II
    Chiara Porta, Mary Poupot-Marsan, Virginie Lafont
    Frontiers in ImmunologyPeer-reviewedCC BYFull textImmunologyHAL
  5. Endothelin receptor blockade potentiates adoptive T cell and CAR T cell therapies
    C. Papagregoiou, F. Mpekris, J. Yoon +14
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{adriani2026microfluidic,
  title = {{Microfluidic models for adoptive cell-mediated cancer immunotherapies}},
  author = {Giulia Adriani and Andrea Pavesi and Anthony T. Tan and Antonio Bertoletti and Jean Paul Thiery and Roger D. Kamm},
  journal = {Drug Discovery Today},
  year = {2026},
  month = oct,
  doi = {10.1016/j.drudis.2016.05.006},
  url = {https://hal.science/hal-05776426v1},
}
RIS
TY  - JOUR
TI  - Microfluidic models for adoptive cell-mediated cancer immunotherapies
AU  - Giulia Adriani
AU  - Andrea Pavesi
AU  - Anthony T. Tan
AU  - Antonio Bertoletti
AU  - Jean Paul Thiery
AU  - Roger D. Kamm
PY  - 2026
DA  - 2026/10/03
JO  - Drug Discovery Today
DO  - 10.1016/j.drudis.2016.05.006
UR  - https://hal.science/hal-05776426v1
SN  - 1359-6446
SN  - 1878-5832
ER  -